Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Pediatrica Health Group Raises USD 28 Million Series B

From Pediatrica Health Group

By

July 8, 2026

Pediatrica Health Group Raises USD 28 Million Series B

Pediatrica Health Group raised USD 28 million in a Series B round led by Valspring Capital with participation from M33 Growth to expand its pediatric primary care network.

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Ladder Health Raises $7 Million Seed Round to Expand Pediatric Developmental Care Platform

Ladder Health Raises $7 Million Seed Round to Expand Pediatric Developmental Care Platform

Ladder Health, a virtual-first pediatric developmental care company, has raised $7 million in an oversubscribed seed financing round led by Nina Capital. The round included participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital, and 7Rock Ventures. The new capital will support expansion across North Carolina, Massachusetts, and Maryland, fund entry into additional markets, enhance the AI-enabled care platform, and deepen partnerships with pediatric practices and health systems.

Jun 22, 2026

Ladder Health Raises $7M to Fix Pediatric Therapy's Waitlist Crisis

Ladder Health Raises $7M to Fix Pediatric Therapy's Waitlist Crisis

Ladder Health, a virtual-first pediatric developmental care company, today announced the close of an oversubscribed $7 million Seed financing round led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, and incubating partner 25madison Health. Other investors include Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital, and 7Rock Ventures. The funding will support expansion across North Carolina, Massachusetts, and Maryland, accelerate entry into additional states, and continue investment in Ladder Health AI-enabled care platform and health system partnerships.

Jun 23, 2026

Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments

Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments

Heidi Health raised a $65 million Series B led by Steven Cohen’s Point72 Private Investments.

Oct 5, 2025

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a four-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics, has raised €100 million ($108 million) in a Series C round of funding led by Israeli VC firm Pitango, constituting a mix of equity and debt. Founded out of Berlin in 2019, Patient21’s platform spans pretty much the whole patient […]

May 21, 2023

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Ladder Health Raises $7 Million Seed Round to Expand Pediatric Developmental Care Platform

Ladder Health Raises $7 Million Seed Round to Expand Pediatric Developmental Care Platform

Ladder Health, a virtual-first pediatric developmental care company, has raised $7 million in an oversubscribed seed financing round led by Nina Capital. The round included participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital, and 7Rock Ventures. The new capital will support expansion across North Carolina, Massachusetts, and Maryland, fund entry into additional markets, enhance the AI-enabled care platform, and deepen partnerships with pediatric practices and health systems.

Jun 22, 2026

Ladder Health Raises $7M to Fix Pediatric Therapy's Waitlist Crisis

Ladder Health Raises $7M to Fix Pediatric Therapy's Waitlist Crisis

Ladder Health, a virtual-first pediatric developmental care company, today announced the close of an oversubscribed $7 million Seed financing round led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, and incubating partner 25madison Health. Other investors include Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital, and 7Rock Ventures. The funding will support expansion across North Carolina, Massachusetts, and Maryland, accelerate entry into additional states, and continue investment in Ladder Health AI-enabled care platform and health system partnerships.

Jun 23, 2026

Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments

Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments

Heidi Health raised a $65 million Series B led by Steven Cohen’s Point72 Private Investments.

Oct 5, 2025

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a four-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics, has raised €100 million ($108 million) in a Series C round of funding led by Israeli VC firm Pitango, constituting a mix of equity and debt. Founded out of Berlin in 2019, Patient21’s platform spans pretty much the whole patient […]

May 21, 2023